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Abstract
Proteins are commonly fused to Escherichia coli maltose-binding protein (MBP) to enhance their yield and
facilitate their purification. In addition, the stability and solubility of a passenger protein can often be
improved by fusing it to MBP. In a previous comparison with two other highly soluble fusion partners, MBP
was decidedly superior at promoting the solubility of a range of aggregation-prone proteins. To explain this
observation, we proposed that MBP could function as a general molecular chaperone in the context of a
fusion protein by binding to aggregation-prone folding intermediates of passenger proteins and preventing
their self-association. The ligand-binding cleft in MBP was considered a likely site for peptide binding
because of its hydrophobic nature. We tested this hypothesis by systematically replacing hydrophobic amino
acid side chains in and around the cleft with glutamic acid. None of these mutations affected the yield or
solubility of MBP in its unfused state. Each MBP was then tested for its ability to promote solubility when
fused to three passenger proteins: green fluorescent protein, p16, and E6. Mutations within the maltose-
binding cleft (W62E, A63E, Y155E, W230E, and W340E) had little or no effect on the solubility of the
fusion proteins. In contrast, three mutations near one end of the cleft (W232E, Y242E, and I317E) dra-
matically reduced the solubility of the same fusion proteins. The mutations with the most profound effect
on solubility were shown to reduce the global stability of MBP.
Keywords: Fusion protein; inclusion bodies; maltose-binding protein; protein folding; solubility; aggre-
gation
Escherichia coli maltose-binding protein (MBP) is often
used as a fusion partner for recombinant protein expression,
primarily because its affinity for maltodextrins allows for
facile purification of fusion proteins by amylose affinity
chromatography (Riggs 2000). Proteins such as MBP, glu-
tathione S-transferase (GST), ubiquitin, and others have also
been observed to increase the yield of their fusion partners
in many cases (Butt et al. 1989; Riggs 2000). In addition,
MBP is often able to promote the solubility of polypeptides
to which it is fused (Pryor and Leiting 1997; Kapust and
Waugh 1999). A recent study demonstrated that not all
highly soluble proteins are equally effective as solubilizing
agents (Kapust and Waugh 1999). In those experiments,
MBP consistently enhanced the solubility of aggregation-
prone proteins, whereas two other commonly used, highly
soluble proteins did not.
Although many investigators have exploited the solubil-
ity-enhancing property of MBP, the mechanism by which
MBP increases the solubility of its passenger proteins is not
understood. One possibility, which seems to be consistent
with all of the available experimental evidence (see below),
is that MBP possesses chaperone-like qualities. These prop-
erties may allow MBP to bind reversibly to folding inter-
mediates of its fusion partners, termed passenger proteins,
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vents their self-association and aggregation. According to
this model (see Fig. 4 in Kapust and Waugh 1999), the
tether that joins the two interacting partners facilitates itera-
tive cycles of binding and release. By preventing the accu-
mulation of a high concentration of unfolded, unseques-
tered passenger protein, this process may eventually steer
the passenger protein toward its native conformation,
provided that it is capable of folding spontaneously in
the environment of the bacterial cytoplasm. In fact, proper
folding of aggregation-prone passenger proteins fused to
MBP has been reported in several cases (Mottershead
et al. 1996; Rao and Bodley 1996; Thomas et al. 1996;
Kapust and Waugh 1999). Alternatively, kinetically trapped
folding intermediates or proteins that aggregate in their na-
tive state may be maintained in a soluble form as MBP
fusions as a result of the formation of a stable sequestered
intermediate. Examples of this behavior have also been
noted (Louis et al. 1991; Lee et al. 1993; Saavedra-Alanis et
al. 1994; Kishore et al. 1998; Sachdev and Chirgwin
1998b).
The way in which chaperones recognize and interact with
their substrates has been the subject of intense investigation.
The 70-kD heat shock protein (Hsp70) family of chaper-
ones, exemplified by E. coli DnaK, interacts with hydro-
phobic regions in nascent polypeptides and prevents them
from aggregating before the acquisition of native structure
(for review, see Feldman and Frydman 2000). The peptide-
binding site of DnaK consists of a deep, hydrophobic pocket
with a particular affinity for leucine side chains (Zhu et al.
1996; Wang et al. 1998). Substrate recognition by the
Hsp60 (or chaperonin) family of chaperones has also been
studied in considerable detail (for recent reviews, see Brazil
and Horowitz 1999; Feltham and Gierasch 2000). The best-
studied member of this family is E. coli GroEL, a large
multisubunit, ring-shaped protein complex that actively pro-
motes the folding of many proteins through an ATP-depen-
dent cycle (for review, see Ranson et al. 1998; Sigler et al.
1998; Wang and Weissman 1999). Binding to the apical
domain in the GroEL complex sequesters the misfolded
protein (or folding intermediate) and may subject it to
physical unfolding forces as the nucleotide triphosphate and
the GroES cochaperonin bind to GroEL and induce confor-
mational changes that release the peptide into the internal
cavity of GroEL (Fenton et al. 1994; Shtilerman et al. 1999).
After iterative cycles of binding and release, the polypeptide
eventually reaches its native conformation. The peptide-
binding region of GroEL, which is located in a cleft between
two -helices on the surface of the apical domain, is mostly
hydrophobic in nature and capable of binding a wide range
of peptide conformations (Buckle et al. 1997; Chatellier et
al. 1999; Chen and Sigler 1999; Kobayashi et al. 1999;
Tanaka and Fersht 1999). In fact, by itself the apical domain
of GroEL, also called the minichaperone, exhibits peptide
binding and limited chaperone activities (Zahn et al. 1996;
Chatellier et al. 1998).
There is no reason to believe that MBP actively partici-
pates in the folding of its fusion partners, but a more pas-
sive, antiaggregative role in peptide binding and sequestra-
tion, as seen with the GroEL minichaperone and Hsp70,
seems plausible. What would the characteristics of such an
interaction site be, if it exists? Should one expect hydro-
phobic character, in accord with peptide-binding sites on
chaperones? MBP has an unusually large number of ex-
posed hydrophobic zones on its surface. Moreover, MBP
possesses a natural protein-binding site that it uses to inter-
act with other proteins involved in maltose signaling and
chemotaxis (Martineau et al. 1990a; Boos and Shuman
1998). In close proximity to this site is a large hydrophobic
cleft (Fig. 1) that specifically binds maltodextrins, causing a
conformational change that closes the cleft and activates the
protein–protein interaction site on the surface (Spurlino et
al. 1991; Quiocho et al. 1997).
Fig. 1. Space-filling representations of the unliganded E. coli MBP crystal
structure (PDB code 1OMP) (Sharff et al. 1992). Amino acids that were
altered by site-directed mutagenesis are highlighted. (A) The amino acids
targeted initially are shown in red. (B) The view in A was rotated back and
to the left to show the additional amino acids (in blue) that were targeted
for mutagenesis.
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maltodextrin-binding cleft may be the site where fused
polypeptides interact with MBP. Foremost among these is
that authentic molecular chaperones (e.g., GroEL and
DnaK) use hydrophobic clefts to bind their targets (Buckle
et al. 1997; Chatellier et al. 1999; Chen and Sigler 1999;
Kobayashi et al. 1999; Tanaka and Fersht 1999). Second,
the presence of this cleft distinguishes MBP from other
highly soluble proteins that do not function effectively as
solubilizing agents (Kapust and Waugh 1999). Third, there
is considerable conformational flexibility associated with
the cleft (Quiocho et al. 1997); therefore, it could adjust its
shape to accommodate a variety of peptides. Finally, if fu-
sion partners interact with MBP by occupying the malto-
dextrin-binding cleft, this could explain why some MBP
fusion proteins do not bind efficiently to amylose resin
(Pryor and Leiting 1997).
Fenton and co-workers (1994) successfully used site-di-
rected mutagenesis to identify functionally important amino
acid side chains in and around the peptide-binding cleft of
GroEL. By systematically changing individual hydrophobic
amino acids to bulky charged side chains, the importance of
these residues for peptide binding by GroEL was demon-
strated (Fenton et al. 1994). Here, we have adopted a similar
approach to examine whether hydrophobic side chains in
the maltodextrin-binding cleft of MBP (Fig. 1A) are impor-
tant for its ability to mediate the solubilizing effect. The
mutant MBPs were assayed for their ability to enhance the
solubility of three passenger proteins that are themselves
poorly soluble when overproduced in E. coli. Unexpectedly,
all but one of the mutations in the cleft had little or no effect
on the solubility of the fusion proteins. In light of these
results, additional mutations were made near but not di-
rectly within the cleft to further define a region on the
surface of MBP that is critical for enhancing the solubility
of its fusion partners. All of the mutant MBPs were also
characterized by equilibrium denaturation methods to assess
the effect of individual mutations on the global stability
of MBP.
Results
Locations of altered amino acids
To test the hypothesis that the maltodextrin-binding cleft in
MBP is involved in promoting the solubility of its fusion
partners, we initially targeted six amino acids within the
cleft (W62, A63, Y155, W230, W232, and W340) for mu-
tagenesis (Fig. 1A). These positions were chosen because of
their aromatic/hydrophobic character and because they span
the length and cover both walls of the cleft. Several of these
amino acids are integral to the maltodextrin-binding site,
but mutations at these positions result in proteins with no
significant structural defects, and they can be expressed and
purified in soluble form (Martineau et al. 1990b). In accord
with the GroEL study (Fenton et al. 1994), the native amino
acid at each position was altered to glutamic acid by oligo-
nucleotide-directed mutagenesis. In every case, the entire
MBP open reading frame was sequenced to ensure that no
unexpected changes were introduced as a consequence of
the mutagenic procedure.
Solubility of mutant MBPs
in the fused and unfused states
Each mutation was first analyzed in the context of native
(unfused) MBP to determine whether the lesion affected the
yield or solubility of MBP by itself. The results of these
experiments are shown in Figure 2A. The electrophoretic
mobility of MBP was altered slightly by some of the mu-
tations, but there was no appreciable difference in yield or
solubility between the wild-type and mutant MBPs.
The six cleft mutations were next tested for their impact
on the solubility of three different fusion proteins. The pas-
senger proteins used for these experiments were p16 (hu-
man cyclin-dependent kinase 4 inhibitor), E6 (human pap-
illomavirus 18 oncoprotein), and GFP (Aequorea victoria
green fluorescent protein). These proteins are insoluble
when they are overproduced in E. coli at 37°C but can be
solubilized very efficiently by fusing them to MBP (Kapust
and Waugh 1999).
p16, a member of the INK4 protein family of tumor sup-
pressors, is composed of four ankryrin (helix–turn–helix)
Fig. 2. Expression of MBPs and MBP fusion proteins. (A) Expression of
unfused MBPs. Each protein was expressed at 37°C in an unfused form and
analyzed by SDS-PAGE. (B) Expression of MBP-p16 fusion proteins. T,
total cellular extract; S, soluble fraction.
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bundles (Russo et al. 1998). The p16 fold is rather unstable,
both in thermodynamic and kinetic terms (Tang et al. 1999).
The propensity of GFP to aggregate when expressed at el-
evated temperatures (e.g., 37°C) is well documented, and
several studies have shown that specific mutations can dra-
matically improve the solubility of the protein under these
circumstances (Cormack et al. 1996; Crameri et al. 1996;
Siemering et al. 1996; Yang et al. 1996; Kimata et al. 1997).
Once folded, however, GFP is exceptionally resistant to
denaturation and can be concentrated to at least 30 mg/ml in
solution without aggregating (Yang et al. 1996). Relatively
little is known about the structure and folding of E6. It is a
small nuclear protein that abrogates the activity of proteins
whose normal function is to negatively regulate cell growth
(Farthing and Vousden 1994). E6 contains two cysteine-
rich, Zn-binding domains.
As shown in Figure 2B, the yields of the mutant MBP–
p16 fusion proteins were substantial and at least as high as
that of the wild-type MBP–p16 fusion protein. Only the
MBP(W232E)–p16 fusion protein exhibited a striking solu-
bility defect. With the possible exception of the W230E
mutation, which appeared to have a slight impact on the
solubility of the MBP–p16 fusion protein, the solubility of
the other mutants was virtually the same as that of the
wild-type fusion protein. Similar results were obtained
when the mutant MBPs were fused to E6 and GFP (Fig.
3A). Thus, only the W232E mutation exhibited the solubil-
ity phenotype expected for a mutation that disrupts an in-
teraction between MBP and its fusion partners: it had no
effect on the solubility of MBP alone, but dramatically re-
duced the solubility of several MBP fusion proteins.
Additional site-directed mutants
One possible explanation for these results is that the inter-
action site overlaps but is not entirely coincident with the
maltodextrin-binding cleft of MBP. The W232 position may
lie at the edge of the interaction site. To test this hypothesis,
we targeted two additional residues (Y242 and I317) for
mutagenesis. These solvent-accessible side chains are situ-
ated outside of the cleft but adjacent to W232 on the surface
of MBP (see Fig. 1B). Although there was no information in
the literature to indicate whether these two side chains are
critical for the proper folding of MBP, the yields and solu-
bilities of unfused Y242E and I317E MBP were virtually
identical to those of wild-type MBP and the other unfused
MBP mutants that we characterized (data not shown).
When examined in the context of the p16, E6, and GFP
fusion proteins, both the Y242E and I317E mutations ex-
hibited severe solubility phenotypes (Fig. 3B). Like
W232E, the Y242E and I317E substitutions dramatically
reduced the solubility of all three fusion proteins tested.
Therefore, this cluster of solvent-accessible side chains evi-
dently is critical for the ability of MBP to promote the
solubility of its fusion partners.
The tyrosyl side chain at position 210 of MBP, which is
solvent-exposed and in the vicinity of the cleft (see Fig. 1B),
was shown previously to be critical for the interaction of
MBP with the MalFGK2 complex; replacement of Tyr210
with a variety of side chains strongly impaired maltose
transport (Szmelcman et al. 1997). However, this tyrosyl
side chain evidently is not important for the solubilizing
activity of MBP, because altering Y210 to alanine had no
effect on the solubility of the MBP fusions tested here (data
not shown).
Mutations on the surface of MBP affect global stability
Although consistent with the interaction site hypothesis, our
results could also be explained if the W232E, Y242E, and
I317E substitutions retard the folding of MBP in the cyto-
plasm. This could affect the solubility of a fusion protein
indirectly by reducing the proportion of MBP that is in a
state capable of promoting solubility, thereby favoring the
kinetically competing pathway of self-association and ag-
Fig. 3. Solubility of MBP fusion proteins. Fusions between each MBP mutant and three passenger proteins (p16, E6, and GFP) were
expressed at 37°C and analyzed by SDS-PAGE. Solubility was estimated by laser scanning densitometry. (A) Cleft mutants. (B)
Additional mutants.
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impact of these mutations on solubility could be due to a
global rather than local effect. To distinguish between these
possibilities, we examined the influence of individual amino
acid substitutions on the stability of MBP in equilibrium
denaturation experiments monitored by circular dichroism
(CD). Each mutant MBP (in the unfused state) was over-
produced, purified to homogeneity, and then subjected to
equilibrium denaturation at 25°C over a wide range of gua-
nidine hydrochloride (Gd-HCl) concentrations. Measure-
ment of ellipticity at 222 nm served as an indication of the
degree of unfolding. Ellipticity data were plotted versus
Gd-HCl concentration and fit to a two-state folding model
using a nonlinear least-squares algorithm (Santoro and
Bolen 1988; Pace and Scholtz 1997). This method of analy-
sis yielded values for the Gd-HCl concentration at the un-
folding transition midpoint as well as the free energy of
unfolding (extrapolated to zero denaturant), G
0
H2O. The
data for each mutant are summarized in Table 1.
All of the mutant MBPs exhibited a sigmoidal, two-state
unfolding transition. Wild-type MBP and most of the cleft
mutants unfolded with a midpoint Gd-HCl concentration
near 1 M, and a G
0
H2O in the range of 10–14 kcal/mole.
These values agree favorably with previously published re-
sults for wild-type MBP (Liu et al. 1988; Diamond et al.
1995; Sheshadri et al. 1999). A few of the mutants appeared
to show small increases in stability to chemical denaturation
relative to wild-type MBP, as indicated by their higher
G
0
H2O values. It is possible that the loss of surface-acces-
sible hydrophobic residues is responsible for this increase in
stability. As a group, the mutations that exhibited a signifi-
cant solubility phenotype are less stable than wild-type
MBP. The free energy of unfolding ranges between 5–8
kcal/mole for these mutants (Table 1). Thus, these data are
consistent with the notion that the solubility defects we
observed may arise from a change in the global stability of
MBP rather than from the disruption of a general protein
interaction site.
To corroborate this conclusion, we investigated the solu-
bility phenotype of one additional mutation. Replacing Tyr-
283 with aspartic acid retards the folding of MBP in vitro
and in vivo (Liu et al. 1988; Chun et al. 1993). Tyr-283 is
situated far away from the cleft in MBP. In accord with
previous observations (Liu et al. 1988; Chun et al. 1993),
our results indicate that Y283D MBP is considerably less
stable than the wild-type protein (Table 1). However, unlike
the other mutations we studied, Y283D MBP exhibited
markedly reduced solubility in its unfused state (Fig. 4). Not
surprisingly, when fused to the three passenger proteins
(p16, E6, and GFP), the Y283D mutation in MBP also had
a severe impact on the solubility of the fusion proteins (Fig.
4). These data are in agreement with the notion that the rate
of folding of MBP is crucial for its ability to promote solu-
bility. Interestingly, Y283D MBP is more stable in equilib-
rium denaturation experiments than some of the other mu-
tants with solubility phenotypes (W232E, Y242E), but its
solubility defect seems to be the most drastic of all.
Discussion
The importance of fusion protein solubility
The ability of MBP to promote the solubility of its fusion
partners may have important applications in the biotechnol-
ogy industry, because insolubility of recombinant proteins
produced in heterologous expression systems is a very com-
mon occurrence (Schein 1989). Although it is sometimes
possible to convert aggregated material into properly
folded, biologically active protein, this is an arduous, costly,
and uncertain undertaking. Consequently, a general means
of circumventing the formation of insoluble protein aggre-
gates is potentially of great practical importance.
It is clear that MBP can routinely enhance the solubility
of diverse fusion partners (Kapust and Waugh 1999), but it
is less certain how often and how efficiently these proteins,
once rendered soluble by fusion to MBP, fold into their
native, biologically active conformations. Some insight into
Fig. 4. Analysis of Y283D MBP and mutant fusion proteins. (A) Expres-
sion of unfused Y283D MBP and Y283D MBP–p16 at 37°C. (B) Solubility
of Y283D MBP fusion proteins at 37°C.
Table 1. Equilibrium unfolding analysis of wild-type and
mutant MBPs
MBP Cm (M Gd-HCl) G°H2O (kCal/mol)
WT 1.08 12.9
W62E 1.05 13.3
A63E 1.07 14.7
Y155E 0.95 10.2
Y210A 1.09 14.0
W230E 0.87 9.8
W232E 0.57 5.4
Y242E 0.68 5.7
Y283D 0.82 6.6
I317E 0.76 7.1
W340E 0.89 10.6
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standing of the mechanism of the solubilizing effect. Elu-
cidating this mechanism may improve our ability to predict
when the use of an MBP fusion will succeed for the pro-
duction of a particular aggregation-prone protein.
Moreover, if the mechanism is known, then it may be
possible to manipulate conditions to further promote the
solubility and proper folding of a greater number of aggre-
gation-prone proteins. Finally, determining the mechanism
of the solubilizing effect may help to further our under-
standing of fundamental aspects of protein folding and ag-
gregation in vivo.
The mechanism of the solubilizing effect
There are at least four possible models that we can invoke
to explain the solubilizing effect of MBP. It should be noted
that these models are not necessarily mutually exclusive.
One possibility is that the fusion proteins form soluble,
micelle-like, multiprotein structures with the hydrophilic
MBP domains on the outside and the aggregated passenger
proteins occupying the center. Although aggregates of a
sort, these particles may not be large enough to be sedi-
mented by centrifugation at low-to-moderate speed. An-
other possibility is that MBP acts as an anchor to restrict the
motion of a slow-folding passenger protein, enabling it to
fold in a more entropically favorable environment by reduc-
ing the number of possible conformations that can be
sampled. A third possibility is that MBP acts as a “chaper-
one magnet” in vivo by channeling chaperones that nor-
mally interact with MBP, such as SecB (Randall et al.
1998), into productive associations with the attached pas-
senger protein. It is also possible that MBP possesses an
intrinsic molecular chaperone activity of its own that be-
comes manifest in the context of a fusion protein. According
to this molecular–chaperone model, MBP enhances the
solubility of its fusion partners by physically interacting
with and sequestering them from self-association during the
folding process (Kapust and Waugh 1999). MBP could also
inhibit the aggregation of proteins in their native states by
the same basic mechanism (i.e., intramolecular association
and sequestration).
The micelle, entropic–anchor, and chaperone–magnet
models seem inconsistent with at least some published ex-
perimental observations. Neither the micelle nor the en-
tropic–anchor model can readily account for the observation
that only a subset of highly soluble proteins, such as MBP,
are effective solubilizing agents (Kapust and Waugh 1999).
Why would not any highly soluble protein be able to form
the proposed micelle-like structures with reasonable profi-
ciency? Similarly, any soluble (and folded) fusion partner
would be expected to exert a similar entropic effect on the
folding of the attached protein. Furthermore, the micelle and
chaperone–magnet models are difficult to reconcile with the
fact that the solubility of MBP fusion proteins is influenced
by the order in which the two domains are translated in
vivo; fusion proteins composed of MBP and either procap-
thepsin D or pepsin were only soluble in cells when MBP
was the amino-terminal domain (Sachdev and Chirgwin
1998a). It is unclear why fusion proteins in which the ag-
gregation-prone passengers are fused to the amino terminus
of MBP would not be able to form micellar structures, as
both termini of MBP are exposed on the surface of the
folded structure (Sharff et al. 1992) and are capable of being
extended without impeding solubility (Tsao et al. 1996; Ka-
pust and Waugh 1999). Nor is it clear why MBP would be
less effective at recruiting chaperones when proteins are
fused to its amino terminus than to its carboxyl terminus.
The fact that the recovery of some purified proteins after in
vitro refolding is enhanced by fusion to MBP (Sachdev and
Chirgwin 1998b) and the observation that MBP inhibits the
aggregation of certain proteins in vitro (Richarme and Cal-
das 1997) are also inconsistent with the chaperone–magnet
model. Thus, none of these models can account for the
existing body of experimental observations.
Chaperone-like activities of MBP
In contrast, all of these observations can be explained if
MBP, and not just any soluble protein, can act as a general
molecular chaperone in the context of a fusion protein (Ka-
pust and Waugh 1999). According to this model, MBP pos-
sesses a site (or sites) with a natural propensity to bind
folding intermediates of the attached protein or aggregation-
prone proteins in their native states. Because the binding site
(or sites) on MBP would not be available until after folding,
this model accounts for the observation that the solubility of
MBP fusion proteins is influenced by the order in which the
two domains are translated in vivo.
A fundamental tenet of the molecular–chaperone model
is that MBP engages in a physical interaction with its fusion
partners, most likely by way of nonspecific hydrophobic
contacts, and that this interaction serves to sequester aggre-
gation-prone folding intermediates and prevent their self-
association. If this is true, then it might be possible to de-
stabilize these interactions by altering hydrophobic amino
acids on the surface of MBP, which could have the effect of
driving the fusion proteins into the kinetically competing,
self-association pathway and lead to the formation of in-
soluble aggregates. This approach succeeded in identifying
residues in GroEL that participate in peptide binding (Fen-
ton et al. 1994). However, the results reported here do not
support the notion that the maltodextrin-binding cleft in
MBP is involved in peptide binding. On the contrary, the
fact that none of the cleft mutations had any effect on the
solubility of several different fusion proteins suggests that
the cleft is not involved in peptide binding. Furthermore, the
fact that the Y210A substitution also had no solubility phe-
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protein-binding site to interact with its fusion partners. Yet,
because our results were negative, we cannot definitively
rule out either of these possibilities.
On the other hand, these site-directed mutagenesis ex-
periments led to the identification of a cluster of solvent-
exposed residues that are absolutely critical for the solubi-
lizing effect. Although they are widely dispersed in the
primary sequence and reside in distinct elements of the sec-
ondary structure, these three side chains form a nearly con-
tiguous patch on the surface of the folded protein (Fig. 1B).
The existence of a solvent-exposed “hot spot” is consistent
with the interaction-site hypothesis. Moreover, if this inter-
pretation is correct, we can also conclude that MBP uses the
same site to interact with different passenger proteins. How-
ever, the correlation we observed between the solubility
phenotypes of these mutations and their influence on the
global stability of MBP in equilibrium denaturation experi-
ments complicates this interpretation. It is also possible that
the W232, Y242, and I317 mutations exert their influence
indirectly by retarding the folding of MBP, which, in turn,
gives rise to the effects we observed on the solubility of
fusion proteins. Our observations regarding destabilization
of MBP by the mutations do not allow us to distinguish
between these two possibilities.
The fact that these three mutations have a destabilizing
effect on MBP does not necessarily contradict the chaper-
one model. Rather, it merely reinforces the idea that the
relatively rapid formation of a properly folded MBP domain
is crucial for its ability to promote solubility. Like the
Y283D substitution (Chun et al. 1993), we suspect that the
mutations we have characterized influence the solubility of
MBP fusion proteins by retarding the rate of MBP folding in
vivo. Preliminary kinetic refolding experiments support this
view (L. Randall, pers. comm.). If we were observing an
equilibrium effect, in which the unfolded state of the mutant
MBPs was always significantly more populated than in the
case of wild-type MBP, then one might expect a lower yield
of the unfused mutant MBPs (due to proteolytic degrada-
tion) or the accumulation of the protein in inclusion bodies,
but neither of these problems occur. Moreover, all of the
mutant MBPs behave normally during purification, suggest-
ing that the vast majority of the protein is properly folded.
The stability of Y283D MBP, as gauged by equilibrium
unfolding experiments, is actually somewhat greater than
that of W232E and Y242E MBP, indicating that a rigorous
correlation between the global stability and the ability to
promote solubility cannot be maintained. Nevertheless, it
seems clear that MBP mutants with impaired stability in
equilibrium unfolding experiments tend to be poorer solu-
bilizing agents. If, as we suspect, the W232E, W242E, and
I317E mutations exert their effect on the solubility of fusion
proteins by retarding the folding of MBP, then we have
identified a new cluster of solvent-accessible residues that
are important for the folding of MBP. Perhaps these resi-
dues were not identified in a genetic selection for mutations
that retard the folding of MBP (Chun et al. 1993) because
the mutagenic specificity of hydroxylamine would not have
generated these lesions. Alternatively, unlike Y283D, their
effects in vivo may be too subtle to be detected by this
method. Further work will be necessary to determine ex-
actly how these mutations influence the folding of MBP and
the solubility of MBP fusion proteins.
Materials and methods
Plasmids
All of the plasmid expression vectors used to produce fused and
unfused MBP were derived from pMAL-c2 (New England Bio-
labs, Inc., Beverly, MA). For the analysis of mutations in the
context of native (unfused) MBP, pMAL-c2 was modified by PCR
to create pDW533, a vector that produces the mature, native form
of MBP. Vectors for expression of fusions between wild-type
MBP and the three “passenger” proteins (p16, E6, and GFP) were
described previously (Kapust and Waugh 1999). These vectors
were named pDW385 (MBP-p16), pRK576 (MBP-E6), and
pDW520 (MBP-GFP).
Mutagenesis
Single amino acid substitutions in MBP were constructed with the
Transformer Site-Directed Mutagenesis Kit (Clontech, Inc., Palo
Alto, CA), using pDW533 as the template. All mutants were con-
firmed by sequencing the entire MBP open reading frame. Appro-
priate restriction enzymes were used to excise each mutation from
the pDW533 derivative and move it into pDW385, pRK576, or
pDW520 to yield the mutant fusion constructs.
Protein expression, SDS-PAGE
analysis, and densitometry
Protein expression was carried out as described previously (Kapust
and Waugh 1999) except that the accessory plasmid pDC952 was
not used in this work. Preparation of total and soluble intracellular
protein samples, SDS-PAGE analysis, and densitometry of the
stained gels were all performed essentially as described (Kapust
and Waugh 1999).
Protein purification
Wild-type MBP and mutants that retained the ability to bind malto-
dextrins (i.e., W232E, Y242E, I317E, and Y283D) were purified
by amylose affinity chromatography according to the instructions
of the manufacturer (New England Biolabs), with minor modifi-
cations. MBP was eluted from the amylose resin with a solution of
20% (w/v) glucose rather than maltose. This modification allows
for much easier removal of the sugar by dialysis at a later step
(D.E. Anderson, unpubl.). MBP mutants with impaired sugar bind-
ing (i.e., W62E, A63E, Y155E, W230E, and W340E), as well as
Y210A MBP, were purified by an alternate method. The insoluble
material froma4Mammonium sulfate cut was removed by cen-
trifugation and the supernatant was applied to a butyl–Sepharose 4
Fox et al.
628 Protein Science, vol. 10Fast Flow column (Amersham Pharmacia Biotech Inc., Piscata-
way, NJ). After the column was washed with 1.5 M ammonium
sulfate, the MBP was eluted with 25 mM HEPES (pH 8). The
fractions containing MBP were pooled, diluted 5-fold with 25 mM
HEPES (pH 8), and then applied to a column of Macro Prep
ceramic hydroxylapatite (BioRad, Inc., Hercules, CA). The col-
umn was washed with 100 mM NaCl, and then the MBP was
eluted with 100 mM phosphate in 25 mM HEPES (pH 8). The
MBP-containing fractions from this column were diluted 5-fold
and applied to a Q-Sepharose Fast Flow column (Amersham Phar-
macia Biotech). The column was washed with 10 mM NaCl and
then the MBP was eluted with 120 mM NaCl. Fractions from the
Q-Sepharose or amylose columns containing purified MBP were
concentrated by diafiltration (Centriplus, Amicon, Inc., Beverly,
MA) and stored at −80°C until needed.
Equilibrium unfolding of MBP
Proteins were thawed and dialyzed into 20 mM phosphate buffer
(pH 7.5) before analysis. Each sample was then diluted to an A280
value of ∼0.7 in the same buffer. Guanidine hydrochloride (Gd-
HCl) denaturation was carried out in a total volume of 40 L with
20 L diluted protein, 4 L buffer (20 mM phosphate at pH 7.5),
0–13 L 5.42 M Gd-HCl, and distilled water to make up the
balance. The concentration of the Gd-HCl stock solution was de-
termined by measuring its refractive index (Pace and Scholtz
1997) using an optical refractometer. The samples were equili-
brated for 16–20 h before determining the extent of unfolding by
CD spectroscopy. CD measurements were acquired in a CD spec-
trometer (Model 202, Aviv Instruments, Inc., Lakewood, NJ) using
a 1-mm path length at 25°C. Measurement of ellipticity at 222 nm
served as an indication of the degree of unfolding. Duplicate
samples were each scanned five times to yield average ellipticity
values. After plotting the average ellipticity versus Gd-HCl con-
centration, nonlinear least-squares analysis was used to fit the data
to equations describing the two-state unfolding of proteins (San-
toro and Bolen 1988; Pace and Scholtz 1997). This analysis
yielded values for the free energy of unfolding (G
0
H2O) as well as
the Gd-HCl concentration at the transition midpoint (Cm).
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